Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Equity Ratio: 2009-2025

Historic Equity Ratio for Aytu Biopharma (AYTU) over the last 17 years, with Jun 2025 value amounting to 0.15.

  • Aytu Biopharma's Equity Ratio fell 28.00% to 0.19 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19, marking a year-over-year decrease of 28.00%. This contributed to the annual value of 0.15 for FY2025, which is 34.92% down from last year.
  • Aytu Biopharma's Equity Ratio amounted to 0.15 in FY2025, which was down 34.92% from 0.23 recorded in FY2024.
  • In the past 5 years, Aytu Biopharma's Equity Ratio ranged from a high of 0.52 in FY2021 and a low of 0.15 during FY2025.
  • Over the past 3 years, Aytu Biopharma's median Equity Ratio value was 0.23 (recorded in 2024), while the average stood at 0.23.
  • In the last 5 years, Aytu Biopharma's Equity Ratio tumbled by 37.83% in 2022 and then grew by 10.42% in 2023.
  • MRY analysis of 5 years shows Aytu Biopharma's Equity Ratio stood at 0.52 in 2021, then tumbled by 37.83% to 0.32 in 2022, then fell by 10.42% to 0.29 in 2023, then dropped by 18.62% to 0.23 in 2024, then crashed by 34.92% to 0.15 in 2025.
  • Its Equity Ratio stands at 0.15 for FY2025, versus 0.23 for FY2024 and 0.29 for FY2023.